common.study.topics.clinical

SAHaRA: A Randomized Controlled Trial

common.study.values.description

“SAHaRA: A Randomized Controlled Trial”

The SAHaRA trial will clarify the role of treating anemia with Red Blood Cell (RBC) transfusion in a unique and vulnerable patient population, and determine whether that impacts on functional outcomes and mortality. It will guide best practice standards and clarify the optimal RBC transfusion strategy in patients with aSAH.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Recruiting patients only common.study.methods.is-healthy-yes

Liberal RBC Transfusion Strategy

RBC transfusion is triggered by a Hemoglobin value of ≤100g/L

Restrictive RBC Transfusion Strategy

Optional RBC transfusion is triggered by a Hemoglobin value of ≤80g/L

participant.views.study.view.additional

participant.views.study.view.scientific-title

Aneurysmal Subarachnoid Hemorrhage - Red Blood Cell Transfusion and Outcome (SAHaRA): A Randomized Controlled Trial

common.study.values.clinical-trial-id

NCT03309579

participant.views.study.view.id

lej1Wd